|
Les Funtleyder has been in the Healthcare industry since 1993. He joined Miller Tabak + Co., LLC in 2004 after managing a Healthcare portfolio for Provident Advisors, a hedge fund in Minneapolis, Minnesota. Prior to joining Provident, Les worked as a medical device analyst at UBS Warburg. Before going to UBS, he covered biotechnology stocks for Bigelow & Company, a Healthcare research boutique in Denver. His industry experience includes directing clinical and business research at Innovative Health Solution, a joint venture of Merck and Wyeth; and as a consultant to HMOs and hospitals for Coopers & Lybrand and Health Strategies Group. Les holds a Master of Public Heath (MPH) from Columbia University and a BA from Tulane University. | 